Inventor · disambiguated record
Daniela Bundschuh
Also filed as: BUNDSCHUH DANIELA
2 granted patents·7 pending applications·10 citations·filing 1999–2005
53Inventor score
Files withALTANA PHARMA AG3ATLANTA PHARMA AG1BEUME ROLF1MAX PLANCK GES ZUR FORDRUNGDER1MAX PLANCK GESELLSCHAFT1
Top patents by PatentIndex Score
9 records- 0145US2006189642A1Synergistic combination comprising roflumilast and an anticholinergic agent selected from ipratropium, oxitropium and tiotropium salts for the treatment of respiratory diseasesALTANA PHARMA AG·Filed 2004·Application pending·0 cites
- 0239US6489327B1Tryptase inhibitorsMAX PLANCK GES ZUR FORDRUNGDER·Filed 1999·Granted Dec 3, 2002·8 cites·10 claims
- 0336US2006147382A1Synergistic combination comprising roflumilast and an anticholinergic agent selected from ipratropium, oxitropium and tiotropium salts for the treatment of respiratory diseasesALTANA PHARMA AG·Filed 2004·Application pending·0 cites
- 0435US2008242681A1N-4-(6-(Hetero)Aryl-Pyrimidin-4-Ylaminophenyl)-Benzenesulfonamides as Kinase InhibitorsALTANA PHARMA AG·Filed 2005·Application pending·0 cites
- 0532US6613769B1Tryptase inhibitorsMAX PLANCK GESELLSCHAFT·Filed 1999·Granted Sep 2, 2003·2 cites·4 claims
- 0631US2006142308A1Synergistic combination comprising roflumilast and formoterolATLANTA PHARMA AG·Filed 2003·Application pending·0 cites
- 0731US2006199865A1Synergistic combination comprising roflumilast and (r,r) - formoterolBEUME ROLF·Filed 2003·Application pending·0 cites
- 0830US2005112069A1Pharmaceutical composition of a pde4 or pde 3/4 inhibitor and histamine receptor antagonistFiled 2003·Application pending·0 cites
- 0929US2005014762A1CombinationFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Daniela Bundschuh files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →